相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Lymphoma and Immunosuppression: A Report of a Case Associated With Efalizumab Therapy
Pamela MacKenzie et al.
CLINICAL LYMPHOMA MYELOMA & LEUKEMIA (2010)
Activated human platelets express β2 integrin
Marie Marthe Philippeaux et al.
EUROPEAN JOURNAL OF HAEMATOLOGY (2010)
Progressive Multifocal Leukoencephalopathy, Efalizumab, and Immunosuppression
Benjamin D. Korman et al.
ARCHIVES OF DERMATOLOGY (2009)
Progressive multifocal leukoencephalopathy after rituximab therapy in HIV-negative patients: a report of 57 cases from the Research on Adverse Drug Events and Reports project
Kenneth R. Carson et al.
BLOOD (2009)
Delayed generalized inflammatory psoriasis flare during efalizumab treatment
B. Martin et al.
BRITISH JOURNAL OF DERMATOLOGY (2009)
Efficacy of Short-Term Cyclosporine Treatment to Control Psoriasis-Related Events during Efalizumab Therapy
Antonio Costanzo et al.
DERMATOLOGY (2009)
Cytomegalovirus Colitis in a Patient Treated with Efalizumab
Anne Caudron et al.
DERMATOLOGY (2009)
Efalizumab: results of a 3-year continuous dosing study for the long-term control of psoriasis
C. Leonardi et al.
BRITISH JOURNAL OF DERMATOLOGY (2008)
Efaliozumab in the treatment of psoriasis: when comorbidity is an issue
Francesca Prignano et al.
DERMATOLOGIC THERAPY (2008)
Disseminated eruptive giant mollusca contagiosa in an adult psoriasis patient during efalizumab therapy
Peter Weisenseel et al.
DERMATOLOGY (2008)
Visceral Leishmaniasis Infection in a Patient with Psoriasis Treated with Efalizumab
Anna Balato et al.
DERMATOLOGY (2008)
Efalizumab-associated thrombocytopenia
Sarah Grim Hostetler et al.
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2007)
Long-term treatment of plaque psoriasis with efalizumab: an Italian experience
A. Costanzo et al.
BRITISH JOURNAL OF DERMATOLOGY (2007)
Complications and adverse reactions in the use of newer biologic agents
Jeffrey P. Callen
SEMINARS IN CUTANEOUS MEDICINE AND SURGERY (2007)
Efalizumab-induced aseptic meningitis
N. Kluger et al.
BRITISH JOURNAL OF DERMATOLOGY (2007)
The incidence of arthropathy adverse events in efalizumab-treated patients is low and similar to placebo and does not increase with long-term treatment: pooled analysis of data from Phase III clinical trials of efalizumab
Carlo Pincelli et al.
ARCHIVES OF DERMATOLOGICAL RESEARCH (2006)
Efalizumab-induced autoimmune pancytopenia
W. L. Tom et al.
BRITISH JOURNAL OF DERMATOLOGY (2006)
Characteristics and antecedents of progressive multifocal leukoencephalopathy in an insured population
P. M. Eng et al.
NEUROLOGY (2006)
Treatment of alopecia areata partim universalis with efalizumab
Ursula Kaelin et al.
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2006)
Problems encountered during anti-tumour necrosis factor therapy
Sheetal B. Desai et al.
BEST PRACTICE & RESEARCH IN CLINICAL RHEUMATOLOGY (2006)
Clinical experience acquired with the efalizumab (Raptiva®) (CLEAR) trial in patients with moderate-to-severe plaque psoriasis:: results from a phase III international randomized, placebo-controlled trial
L. Dubertret et al.
BRITISH JOURNAL OF DERMATOLOGY (2006)
Successful treatment of severe atopic dermatitis in a child and an adult with the T-cell modulator efalizumab
JM Weinberg et al.
ARCHIVES OF DERMATOLOGY (2006)
Safety of efalizumab in adults with chronic moderate to severe plaque psoriasis: A phase IIIb, randomized, controlled trial
KA Papp et al.
INTERNATIONAL JOURNAL OF DERMATOLOGY (2006)
Treatment of refractory subacute cutaneous lupus erythematosus with efalizumab
TH Clayton et al.
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2006)
Long-term continuous efalizumab therapy in patients with moderate to severe chronic plaque psoriasis: Updated results from an ongoing trial
AB Gottlieb et al.
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2006)
Anti-inflammatory - Efalizumab: a review of events reported during clinical trials and side effects
Noah Scheinfeld
EXPERT OPINION ON DRUG SAFETY (2006)
Treatment of generalized lichen planus with alefacept
DP Fivenson et al.
ARCHIVES OF DERMATOLOGY (2006)
A review of malignancies observed during efalizumab (Raptiva (R)) clinical trials for plaque psoriasis
Craig L. Leonardi et al.
DERMATOLOGY (2006)
Treatment of recalcitrant dermatomyositis with efalizumab
Andrea Huber et al.
ACTA DERMATO-VENEREOLOGICA (2006)
Severe exacerbation of psoriatic arthritis during treatment with efalizumab. A case report
Bo Bang et al.
ACTA DERMATO-VENEREOLOGICA (2006)
Immune thrombocytopenia associated with efalizumab therapy for psoriasis
TE Warkentin et al.
ANNALS OF INTERNAL MEDICINE (2005)
Efalizumab for the treatment of moderate to severe plaque psoriasis
JK Jordan
ANNALS OF PHARMACOTHERAPY (2005)
Brief report - Progressive multifocal leukoencephalopathy complicating treatment with natalizumab and interferon beta-1a for multiple sclerosis
BK Kleinschmidt-DeMasters et al.
NEW ENGLAND JOURNAL OF MEDICINE (2005)
Brief report - Progressive multifocal leukoencephalopathy in a patient treated with natalizumab
A Langer-Gould et al.
NEW ENGLAND JOURNAL OF MEDICINE (2005)
Brief report - Progressive multifocal leukoencephalopathy after natalizumab therapy for Crohn's disease
G Van Assche et al.
NEW ENGLAND JOURNAL OF MEDICINE (2005)
Extended efalizumab therapy improves chronic plaque psoriasis: Results from a randomized phase III trial
CL Leonardi et al.
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2005)
Clinical considerations of efalizumab therapy in patients with psoriasis
TK Hamilton
SEMINARS IN CUTANEOUS MEDICINE AND SURGERY (2005)
Incidence of infection during efalizumab therapy for psoriasis: Analysis of the clinical trial experience
RGB Langley et al.
CLINICAL THERAPEUTICS (2005)
Efficacy and safety observed during 24 weeks of efalizumab therapy in patients with moderate to severe plaque psoriasis
A Menter et al.
ARCHIVES OF DERMATOLOGY (2005)
Potential of tumor necrosis factor inhibitors in psoriasis and psoriatic arthritis
G Krueger et al.
ARCHIVES OF DERMATOLOGY (2004)
Disseminated granuloma Annulare resolved with the T-cell modulator efalizumab
BS Goffe
ARCHIVES OF DERMATOLOGY (2004)
Efalizumab for patients with moderate to severe plaque psoriasis - A randomized controlled trial
KB Gordon et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2003)
A novel targeted T-cell modulator, efalizumab, for plaque psoriasis
M Lebwohl et al.
NEW ENGLAND JOURNAL OF MEDICINE (2003)
Methotrexate versus cyclosporine in moderate-to-severe chronic plaque psoriasis
VMR Heydendael et al.
NEW ENGLAND JOURNAL OF MEDICINE (2003)
Infections and biological therapy in rheumatoid arthritis
G Cunnane et al.
BEST PRACTICE & RESEARCH IN CLINICAL RHEUMATOLOGY (2003)
Infection complications associated with the use of biologic agents
B Bresnihan et al.
RHEUMATIC DISEASE CLINICS OF NORTH AMERICA (2003)
The combination of calcipotriol and methotrexate compared with methotrexate and vehicle in psoriasis: results of a multicentre placebo-controlled randomized trial
EMGJ de Jong et al.
BRITISH JOURNAL OF DERMATOLOGY (2003)
Aplastic anemia following administration of a tumor necrosis factor-alpha inhibitor
J Kuruvilla et al.
EUROPEAN JOURNAL OF HAEMATOLOGY (2003)
The treatment of moderate to severe psoriasis with a new anti-CD11a monoclonal antibody
K Papp et al.
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2001)
Squamous-cell cancer of the skin in patients given PUVA and ciclosporin: nested cohort crossover study
I Marcil et al.
LANCET (2001)
Efficacy and safety of infliximab monotherapy for plaque-type psoriasis: a randomised trial
U Chaudhari et al.
LANCET (2001)
The immune system - First of two parts
PJ Delves et al.
NEW ENGLAND JOURNAL OF MEDICINE (2000)
Effects of administration of a single dose of a humanized monoclonal antibody to CD11a on the immunobiology and clinical activity of psoriasis
A Gottlieb et al.
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2000)
分享论文
